Spontaneous retroperitoneal hematoma in a patient with SARS-CoV-2
DOI:
https://doi.org/10.32818/reccmi.a6n1a7Keywords:
SARS-CoV-2, heparin, retroperitoneal hematoma.Abstract
The association of retroperitoneal hematoma and anticoagulant treatment has been described in a few cases. Since heparin treatment has been introduced as part of the treatment protocols in patients with SARS-CoV-2, a review of only two spontaneous retroperitoneal hematomas in patients admitted to our hospital. These patients with associated pneumonia to COVID-19 during the alarm state received low molecular weight heparin at anticoagulant doses.
Downloads
Metrics
References
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18(5): 1094-1099. doi: https://doi.org/10.1111/jth.14817.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E et al; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(23): 2950-2973. doi: https://doi.org/10.1016/j.jacc.2020.04.031.
Salemis NS, Oikonomakis I, Lagoudianakis E, Boubousis G, Tsakalakis C, Sourlas S et al. Enoxaparin-induced spontaneous massive retroperitoneal hematoma with fatal outcome. Am J Emerg Med. 2014; 32(12): 1559.e1-3. doi: https://doi.org/10.1016/j.ajem.2014.05.026.
Daliakopoulos SI, Bairaktaris A, Papadimitriou D, Pappas P. Gigantic retroperitoneal hematoma as a complication of anticoagulation therapy with heparin in therapeutic doses: a case report. J Med Case Rep. 2008; 2: 162. doi: https://doi.org/10.1186/1752-1947-2-162.
Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM et al; Revisores expertos. Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología. Rev Esp Cardiol. 2020 Sep;73(9):749-757. doi: https://doi.org/10.1016/j.recesp.2020.04.006.
Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020; 395(10228): e52. doi: https://doi.org/10.1016/S0140-6736(20)30558-4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ana González-Torre-González, Tamara Gómez-Traveso, Raquel Jaso-Tejera, Elena Casuso-Sáenz, Nuria Díez-Herrán
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
